Faculty profile

Pierre Duquette

ResearcherNeurologieUniversité de Montréal

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses may be missing. Find their university profile.

Pierre Duquette

Researcher

Neurologie

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
42 publications in the last five years, latest in 2026.
Senior (last) author on 3 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2019.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

104

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Cannabis Knowledge Transfer Multidisciplinary Team Multiple Sclerosis People With Lived Experience Randomized Clinical Trial Spasticity

Latest papers

Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis.
Brain : a journal of neurology · 2026
Managing reactivation of multiple sclerosis during treatment with natalizumab.
Multiple sclerosis (Houndmills, Basingstoke, England) · 2026
Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study.
Multiple sclerosis (Houndmills, Basingstoke, England) · 2026

All 104 publications

Latest funding

Is cannabis a useful adjunct in the treatment of symptoms of persons with multiple sclerosis? A formal trial of CBD and THC for the control of spasticity and other symptoms: assessing the clinical effects and the basic mechanisms.
CIHR · 2019 · Nominated PI
$750,000
Bacillus Calmette-Guerin (BCG) vaccination and multiple sclerosis: a population-based study in Quebec
CIHR · 2015 · Co-investigator
$100,000
Getting on with your life with MS: A Knowledge Translation Tool
CIHR · 2011 · Co-investigator
$100,000

All 5 grants and awards

104 publications.

Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis.

Daruwalla C, Kremler C, Patti F, Ozakbas S, Boz C, Lechner-Scott J, Surcinelli A, Foschi M, Khoury SJ, Butzkueven H, van der Walt A, Rous Z, Habek M, Meca-Lallana JE, Lopez GV, Alroughani R, Blanco Y, Laureys G, Skibina O, Buzzard K, Gray O, McCombe P, Maimone D, Duquette P, Girard M, Prat A, Sanchez-Menoyo JL, van Pesch V, Soysal A, Amato MP, Grand'Maison F, Wilton J, Van Wijmeersch B, Gerlach O, Lugaresi A, Tomassini V, De Luca G, Taylor B, Foong YC, John N, Cárdenas-Robledo S, Hodgkinson S, Macdonell R, Willekens B, Garber J, D'Amico E, Terzi M, Houskova J, Lapointe E, Al-Asmi A, Barnett M, Stetkarova I, Gouider R, Mrabet S, Csepany T, McGuigan C, Gross-Paju K, Kuhle J, Castillo-Triviño T, Kerrigan S, Tolkovsky AM, Wardle M, Cunniffe NG, Roos I, Madley-Dowd P, Coles A, Kalincik T, Sterne JAC, William Brown JL, MSBase study group

Brain : a journal of neurology2026

DOI: 10.1093/brain/awag252 PMID: 42496160

Managing reactivation of multiple sclerosis during treatment with natalizumab.

Lizak N, Sharmin S, Horáková D, Havrdova EK, Eichau S, van der Walt A, Butzkueven H, Lechner-Scott J, Buzzard K, Skibina O, Gerlach O, Prat A, Girard M, Duquette P, Alroughani R, Patti F, Grand'Maison F, Sá MJ, Aguera-Morales E, Hodgkinson S, Grammond P, Kuhle J, Yamout B, Khoury SJ, Ozakbas S, Csepany T, John N, Laureys G, Terzi M, Amato MP, Boz C, Al-Asmi A, Cartechini E, Gouider R, Mrabet S, Roos I, Kalincik T

Multiple sclerosis (Houndmills, Basingstoke, England)2026

DOI: 10.1177/13524585251398682 PMID: 41420376

Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study.

Nesbitt C, Sanfilippo P, Zhu C, Ozakbas S, Prat A, Girard M, Duquette P, Kalincik T, Roos I, Buzzard K, Skibina O, Foschi M, Surcinelli A, Lechner-Scott J, Patti F, Kermode AG, Fabis-Pedrini M, Carroll WM, Hodgkinson S, Grand'Maison F, Havrdova EK, Hradilek P, Habek M, Maimone D, Alroughani R, Vachova M, van Pesch V, Macdonell R, Spitaleri D, Khoury SJ, Gerlach O, de Gans K, McCombe P, Van Der Walt A, Butzkueven H, Jokubaitis V

Multiple sclerosis (Houndmills, Basingstoke, England)2026

DOI: 10.1177/13524585261460658 PMID: 42543909

Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis.

Müller J, Sharmin S, Lorscheider J, Ozakbas S, Karabudak R, Horakova D, Weinstock-Guttman B, Shaygannejad V, Etemadifar M, Alroughani R, Patti F, Eichau S, Prat A, Lugaresi A, Tomassini V, Kermode AG, Amato MP, Turkoglu R, Altintas A, Buzzard K, Soysal A, van der Walt A, Butzkueven H, Blanco Y, Gerlach O, Khoury SJ, Barnett M, John N, Lechner-Scott J, Foschi M, Surcinelli A, van Pesch V, Prevost J, Sa MJ, Maimone D, D'hooghe M, Hughes S, Hodgkinson S, McGuigan C, Cartechini E, Taylor B, Spitaleri D, Slee M, McCombe P, Yamout B, Benkert P, Kuhle J, Kappos L, Roos I, Kalincik T, MSBase Study Group, Havrdova EK, Girard M, Duquette P, Fabis-Pedrini M, Carroll WM, Skibina O, Gouider R, Mrabet S, Ramo-Tello C, Solaro C, Habek M, Van Wijmeersch B, Ampapa R, Macdonell R, Oreja-Guevara C, de Gans K, Laureys G, Oh J, Garber J, Gray O, Agüera-Morales E, Sanchez-Menoyo JL, Castillo-Triviño T, Grigoriadis N, Petersen T, Hardy TA, Vucic S, Reddel S, Ramanathan S, Al-Asmi A, Simu M, Baghbanian SM, Poehlau D, Al-Harbi T, Rojas JI, Deri N, Lalive P, Cambron M, Csepany T, Shuey N, Willekens B, Shaw C, Decoo D, Massey J, Yaldizli Ö, Derfuss T, Granziera C

JAMA neurology2025

DOI: 10.1001/jamaneurol.2025.0495 PMID: 40227706

First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis.

Toscano S, Spelman T, Ozakbas S, Alroughani R, Chisari CG, Lo Fermo S, Prat A, Girard M, Duquette P, Izquierdo G, Eichau S, Grammond P, Boz C, Kalincik T, Blanco Y, Buzzard K, Skibina O, Sa MJ, van der Walt A, Butzkueven H, Terzi M, Gerlach O, Grand'Maison F, Foschi M, Surcinelli A, Barnett M, Lugaresi A, Onofrj M, Yamout B, Khoury SJ, Prevost J, Lechner-Scott J, Maimone D, Amato MP, Spitaleri D, Van Pesch V, Macdonell R, Cartechini E, de Gans K, Slee M, Castillo-Triviño T, Soysal A, Sanchez-Menoyo JL, Laureys G, Van Hijfte L, McCombe P, Altintas A, Weinstock-Guttman B, Aguera-Morales E, Etemadifar M, Ramo-Tello C, John N, Turkoglu R, Hodgkinson S, Besora S, Van Wijmeersch B, Fernandez-Bolaños R, Patti F, MSBase Study Group

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2025

DOI: 10.1016/j.neurot.2025.e00552 PMID: 39965993

Cognitive and affective theory of mind in young and elderly patients with multiple sclerosis.

Montembeault M, Farley R, Ouellet J, Brando E, Tremblay A, Charest K, Roger É, Scherzer P, Duquette P, Rouleau I

Journal of neuropsychology2025

DOI: 10.1111/jnp.12382 PMID: 38982586

Peripheral blood age-sensitive immune markers in multiple sclerosis: relation to sex, cytomegalovirus status, and treatment.

Desu H, Balthazard R, Daigneault A, Da Cal S, Klément W, Yu J, Clénet ML, Margarido C, Levert A, Fantodji C, Tastet O, Girard JM, Duquette P, Prat A, Macaron G, Rousseau MC, Arbour N, Larochelle C

EBioMedicine2025

DOI: 10.1016/j.ebiom.2025.105559 PMID: 39837012

Real-world effectiveness of horizontal switching between disease-modifying therapies in multiple sclerosis: a retrospective analysis of the MSBase Registry.

Gomez-Figueroa E, Orozco-Puga P, Corona-Vázquez CP, Moreno-Bernardino C, Elizabeth De la Mora-Landín G, Jiménez-Ruiz A, García-Estrada C, Zertuche-Ortuño L, Saldívar-Dávila S, Rodríguez-Rivas R, Bazán-Rodríguez L, Flores-Rivera J, Kalincik T, Buzzard K, Khoury S, Duquette P, Foschi M, Surcinelli A, Weinstock-Guttman B, Gouider R, Mrabet S, Lechner-Scott J, Butzkueven H, Alroughani R, Roos I, Patti F, Yamout B, Grand'Maison F, Spitaleri D, McCombe P, Luis Sanchez-Menoyo J, Ozakbas S, Al-Asmi A, John N, Cartechini E, Van der Walt A, Garber J, Lapointe E, Soysal A, Aguera-Morales E, Guimarães J, Ruiz-Sandoval JL

Therapeutic advances in neurological disorders2025

DOI: 10.1177/17562864251399595 PMID: 41466847

Corticosteroid treatment of multiple sclerosis relapses is associated with lower disability worsening over 5 years.

Roberts JI, Sharmin S, Horakova D, Kubala Havrdova E, Ozakbas S, Lugaresi A, Tomassini V, Alroughani R, Buzzard K, Skibina O, Boz C, Turkoglu R, Maimone D, Yamout B, Khoury SJ, Spitaleri D, Lechner-Scott J, Girard M, Duquette P, Al-Asmi A, Ampapa R, Foschi M, Surcinelli A, Patti F, Van Pesch V, Ramo-Tello C, Sánchez-Menoyo JL, Altintas A, Grammond P, Cartechini E, Csepany T, Laureys G, Willekens B, Roos I, Kalincik T, Study Group M

Journal of neurology, neurosurgery, and psychiatry2025

DOI: 10.1136/jnnp-2025-336343 PMID: 40721309

Addressing patient-reported cognitive impairment in multiple sclerosis clinical practice: A challenging endeavor.

Macaron G, Farah N, Charbonneau S, Morrow SA, Zertal A, Saint-Amour D, Duquette P, Rouleau I

Multiple sclerosis (Houndmills, Basingstoke, England)2025

DOI: 10.1177/13524585251334488 PMID: 40247705

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2019

Subject: Prospective PhD student: Cannabis Dear Professor Duquette, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Is cannabis a useful adjunct in the treatment of symptoms of persons with multiple sclerosis? A formal trial of CBD and THC for the control of spasticity and other symptoms: assessing the clinical effects and the basic mechanisms." (2019), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Pierre Duquette

Research

Latest papers

Latest funding

Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis.

Managing reactivation of multiple sclerosis during treatment with natalizumab.

Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study.

Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis.

First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis.

Cognitive and affective theory of mind in young and elderly patients with multiple sclerosis.

Peripheral blood age-sensitive immune markers in multiple sclerosis: relation to sex, cytomegalovirus status, and treatment.

Real-world effectiveness of horizontal switching between disease-modifying therapies in multiple sclerosis: a retrospective analysis of the MSBase Registry.

Corticosteroid treatment of multiple sclerosis relapses is associated with lower disability worsening over 5 years.

Addressing patient-reported cognitive impairment in multiple sclerosis clinical practice: A challenging endeavor.

Is cannabis a useful adjunct in the treatment of symptoms of persons with multiple sclerosis? A formal trial of CBD and THC for the control of spasticity and other symptoms: assessing the clinical effects and the basic mechanisms.

Bacillus Calmette-Guerin (BCG) vaccination and multiple sclerosis: a population-based study in Quebec

Getting on with your life with MS: A Knowledge Translation Tool

The Role of Exercise in Modifying Outcomes for People with Multiple Sclerosis: A Randomized Trial

CIHR Integrated Training Program in Basic and Clinical Aspects of Neuroinflammation

Frequent collaborators

Alexandre Prat

Catherine Larochelle

Nathalie Arbour

Jiwon Oh

Elie Haddad

Andrea Benedetti

Marie-Pascale Pomey

Marie-Claude Rousseau

Didier Jutras-Aswad

Susan Bartlett

Marta Kaminska

Anthony Traboulsee

Maxime Montembeault

Harold Atkins

Giulia Fadda

Fabrizio Giuliani

Maryam Oskoui

Ruth Barclay

Mark Keezer

Xavier Montalban

Ayse Kuspinar

Elana Pinchefsky

Jacques Montplaisir

Helen Tremlett

Christina Wolfson